CTRI/2026/04/109234尚未招募不适用
Effectiveness of National Tobacco Quitline Services (NTQLS) in cessation among smokeless tobacco (SLT) users: A randomised controlled trial in Tertiary care Hospital, Odisha
Dr SATYAPRABHA ROUT1 个研究点 分布在 1 个国家目标入组 264 人开始时间: 2026年7月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 264
- 试验地点
- 1
- 主要终点
- Point prevalence abstinence from smokeless tobacco use at 4,8,12,24 weeks
研究概览
简要总结
This study evaluates the effectiveness of National Tobacco Quitline Services (NTQLS) in helping smokeless tobacco users quit. It is a randomized controlled trial conducted among 264 participants at a tertiary care hospital in Odisha, comparing behavioural counselling alone with counselling plus quitline support. Participants will be followed for 24 weeks to assess abstinence, quit attempts, and relapse. The findings aim to determine whether NTQLS improves cessation outcomes and can serve as an effective, accessible public health strategy for tobacco control.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients of all age groups referred to TCC of SCB Dental College and Hospital, Cuttack will be included in the study.
- •2.Individuals who are current users of smokeless tobacco products (such as gutkha, khaini, pan masala with tobacco, snuff, or other forms).
- •3.Individuals who are willing to quit smokeless tobacco.
- •4.Individuals willing to participate in the cessation intervention.
排除标准
- •1.Individuals who consume or use smoked tobacco products only (cigarettes/bidis) without smokeless tobacco use.
- •2.Individuals who are currently enrolled in any other tobacco cessation program or clinical trial.
- •3.Individuals receiving pharmacotherapy for tobacco cessation (nicotine replacement therapy, bupropion, varenicline, or other medications) at the time of recruitment.
- •4.Individuals with serious medical illnesses or unstable systemic conditions that may interfere with participation or follow-up (e.g., severe cardiac disease, uncontrolled diabetes, or malignancy).
- •5.Individuals with psychiatric disorders or cognitive impairment that limit their ability to provide reliable information or informed consent.
- •6.Individuals who are not willing to provide informed consent or unable to comply with the study protocol and scheduled follow-up visits.
- •7.Participants who plan to relocate or are unlikely to be available for the 24-week follow-up period.
结局指标
主要结局
Point prevalence abstinence from smokeless tobacco use at 4,8,12,24 weeks
时间窗: 4,8,12,24 weeks
次要结局
- 1.Prolonged abstinence (continuous cessation) over a period of 24 weeks(2.Number and frequency of quit attempts)
研究者
Dr SATYAPRABHA ROUT
SCB DENTAL COLLEGE AND HOSPITAL,CUTTACK,ODISHA, Odisha
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
A study to know quitting of tobacco among tobacco chwewers after habit cessation counselling and nicotine replacement therapyTobacco Chewing Habit PatientsCTRI/2025/11/097866Indian Cancer Society Mumbai172
尚未招募
不适用
Effect of smoking cessation package on health related quality of life among Chronic Obstructive Pulmonary Disease patients attending Chest Medicine Out Patient Department of Bankura Sammilani Medical College and Hospital: A Quasi Experimental Study.Chronic obstructive pulmonary disease, unspecified,CTRI/2025/02/080610Dr Anirban Nandy120
尚未招募
不适用
Evaluating the Impact of a Brief Educational Intervention on Tobacco Cessation Among Adults in a Rural Community.F17. Mental and behavioural disorders due to use of tobacco.CTRI/2025/08/093296Dr. NTR University of Health Sciences400
已完成
不适用
Developing a Community Support Program to Help People Quit Smoking.Smoking CessationNCT07432152Mahidol University80
尚未招募
2 期
Smoke-Free: A Mobile App Intervention to Help People Quit SmokingNicotine dependence,CTRI/2024/12/078597Saveetha medical college30